Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio

Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio

Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase price of USD 2.7 billion, with additional milestone payments of up to USD 400 million. Carmot Therapeutics’ Incretin Portfolio: A Boon for Obesity Treatment The acquisition provides Roche access to Carmot Therapeutics’ innovative portfolio of incretins, which […]

Roche announces $7.1bn deal to acquire Telavant and RVT-3101 antibody

Roche announces $7.1bn deal to acquire Telavant and RVT-3101 antibody

Switzerland-based Roche has officially declared its acquisition agreement for Telavant Holdings, Inc., a Roivant company collaboratively owned by Roivant Sciences Ltd. and Pfizer Inc. The spotlight of this $7.1 billion deal is on RVT-3101, a novel TL1A directed antibody, poised as a potential game-changer for nearly 8 million global inflammatory bowel disease patients, including those […]

Roche launches Elecsys Anti-p53 immunoassay to help in cancer diagnosis

Roche launches Elecsys Anti-p53 immunoassay to help in cancer diagnosis

Swiss healthcare company Roche has launched the Elecsys Anti-p53 immunoassay to help in the diagnosis of various types of cancer by the in vitro quantitative determination of anti-p53 antibodies. The Anti-p53 immunoassay test will help physicians in diagnosing oesophageal cancer, breast cancer, and bowel cancer in patients, in combination with other diagnostic tests, said Roche. […]

Roche to acquire molecular diagnostic solutions firm GenMark Diagnostics

Roche to acquire molecular diagnostic solutions firm GenMark Diagnostics

Roche has agreed to acquire US-based molecular diagnostic solutions provider GenMark Diagnostics for $24.05 per share or about $1.8 billion in an all-cash deal. GenMark Diagnostics offers molecular diagnostic tests that can detect multiple pathogens from a single patient sample. According to Roche, the syndromic panel testing portfolio of GenMark Diagnostics will complement its current […]

Roche acquires DNA sequencing technology company Stratos Genomics

Roche acquires DNA sequencing technology company Stratos Genomics

Roche acquisition of Stratos Genomics : Swiss pharma giant Roche has acquired US-based early-stage DNA sequencing technology company Stratos Genomics for an undisclosed price. The transaction is expected to help Roche advance the development of its nanopore sequencer through the access to Sequencing by Expansion (SBX), Stratos Genomics’ unique chemistry. Roche said that once developed, […]

Roche launches v-TAC blood gas digital solution

Roche launches v-TAC blood gas digital solution

Swiss healthcare company Roche has launched a new blood gas digital solution called Roche v-TAC, which is said to be designed to enhance patient care. The new digital diagnostic solution is said to help clinicians to get better results for arterial blood gas values from patients having respiratory or metabolic abnormalities by using a less […]